SCRS Talks

Technology has the power to reduce the burden on overworked sites–but only if that technology is well-integrated. Catherine Gregor, Chief Clinical Trial Officer at Florence Healthcare, shares insights from her session at the 2022 Global Oncology Site Solutions Summit on challenges and opportunities with site-centric technology. Listen as Catherine shares how sites and Sponsors can ensure they are working together to develop mutually beneficial solutions.

Commemorating a decade since the organization's inception, SCRS spoke with one of our first clinical research site members, Richard Pollack with Evolution Research Group.  Dr. Pollack shines a light on how he was introduced to SCRS and some of his fond memories with the organization while reflecting on how the industry has changed.

Decentralized clinical trial (DCT) technology has the opportunity to create more effective, efficient, and accessible clinical trials. Now that research sites have more experience with these systems, we also have a better understanding of their challenges and opportunities. Craig Lipset, advisor and founder of Clinical Innovation Partners and co-chair of the Decentralized Trials & Research Alliance shares what the clinical trials industry has learned about DCTs and how we can move forward together.

The clinical research industry is currently seeing an unprecedented rise of sites facing financial burden due to increasing costs of staffing and supplies. Now more than ever, it's critical that sites learn what actions they can take to ensure they understand what they are agreeing to in clinical trial agreements and what flexibility they have. Daniel Fox, Ph.D., founder and CEO of the Clinical Research Payment Network,  shares what to look for in CTAs to ensure they are in the site's best interest and how to establish a mutual relationship of trust with industry partners.

SCRS recently held its fourth annual Global Oncology Site Solutions Summit in Austin, Texas. It was an incredible two-day event with actionable insights and best practices specific to oncology clinical research. In this episode, we speak with Peter Fredette, a long-standing member of the SCRS Oncology program and our new Global Oncology Summit chair, to discuss some highlights from this year's conference and what we can expect for the future of the program.

Patient-centricity has been a hot topic in clinical research. Recently the industry has realized that to truly be patient-centric, you must also be site-centric. Deena Bernstein, Vice President of Customer Success at Datacubed, discusses what it means to be site and participant centric in clinical trials and how to reduce the burden of technology for both patients and sites.

The implementation of decentralized tools and technologies has drastically changed study start-up and training requirements that have placed an additional burden on clinical research sites. SCRS spoke with Todd Albin, CEO of Cedar Health Research to discuss how sites can prepare for these changes and ensure all industry stakeholders are working together to ensure efficiency and sustainability with technology in trials.

The 2022 Australia-New Zealand Summit is quickly approaching! ANZ Summit chairs Cheryl-Ann Hawkins, Chief Operating Officer at Emeritus Research and Tam C. Nguyen, Deputy Director of Research at St. Vincent’s Hospital Melbourne, share what they are most excited about for this year's Summit, sessions they are looking forward to, and how to maximize your experience. Learn more and register today at https://apsitesolutionssummit.com

Holdback payments evolved as a way for industry sponsors and CROs to ensure that their clinical research sites were completing the necessary work throughout a trial. However, holdback payments have been a long-standing issue for sites. 

Vivienne van de Walle, co-founder of PreCare Trial & Recruitment, shares lessons learned from working with sponsors and CROs to eliminate this practice, and tips for sites to successfully negotiate to have their study costs covered.

The industry is currently facing unprecedented macroeconomic issues including substantial staffing challenges and inflationary pressures.  In response, SCRS formed a task force committee, which provides resources for both sites and industry to collaborate to address these issues.

David Vulcano, SCRS Honorary President and VP of Clinical Research Compliance & Integrity at HCA Healthcare speaks with William Smith, co-chair of the SCRS task force and CEO of Alliance Speciality Research and Jeff Kingsley, CEO of Centricity Research and task force member, to talk through what the committee is doing to mitigate these challenges and how our industry partners can help.